Hürthle cell carcinoma: a clinicopathological study of thirteen cases

Nuclear Medicine Communications

Volumn 27, Issue 4, 2006, Pages 377-379

  Ozlem Kucuk N ^a   Kulak, Hülya ^a   Tokmak, Emel ^a   İbiş, Erkan ^a   Aras, Gülseren ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Hurthle cell carcinoma; Radioiodine therapy; Response distant metastases

Indexed keywords

RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; IODINE 131; THYROGLOBULIN;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; MALE; MIDDLE AGED; ONCOCYTOMA; THYROID TUMOR; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CHILDHOOD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FOLLOW UP; HEAD AND NECK CARCINOMA; LOW ENERGY RADIATION; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL EXAMINATION; PATHOLOGY; PATIENT MONITORING; RADIATION DOSE; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROID SCINTISCANNING;

ADENOMA, OXYPHILIC; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 33746892296     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000202862.74917.0c     Document Type: Article

References (18)

1. Hundahl SC, Fleming ID, Fremgen AM, Mench HR. A national cancer database report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998; 82:2638-2648.
2. Cooper DS, Schneyer CR. Follicular and Hurthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am 1990; 19:577-591.
3. Hamann A, Gratz KF, Soudah B, Fritsch RS, Georgi A, Hundeshagen H. The clinical course of oxyphilic carcinoma of the thyroid. Nuklearmedizin 1992; 31:230-238.
4. Har-el G, Hadar T, Segal K, Levy R, Side J. Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer 1986; 57:1613-1617.
5. Tollefsen HR, Shah JP, Huvos AG. Hurthle cell carcinoma of the thyroid. Am J Surg 1975; 130:390-394.
6. Watson RG, Brennan MD, Goellner JR, van Herden JA, McConahey WM, Taylor WF. Invasive Hürthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc 1984; 59:851-855.
7. McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J. Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 1996; 120:1000-1005.
8. Janser JC, Solis C, Rodier JF, Ghnassia JP. Oncocytic cancers of the thyroid. Hürthle cell cancers. Chirurgie 1996; 121:28-36.
9. Ruegemer JJ, Hay ID, Bergstrahl E J, Ryan JJ, Offord Kp, Gormon CA. Distant metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 1988; 67:501-508.
10. Sanders L, Silverman M. Follicular and Hurthle cell carcinoma: predicting outcome and directing therapy. Surgery 1998; 124:967.
11. Arganini M, Behar R, Wu T-C, Straus F 2nd, McCormick M, De Groot L J, Kaplan EL. Hurthle cell tumors: a twenty-five-year experience. Surgery 1986; 199:1108.
12. Sugino K, Ito K, Mimura T, Komeyama K, Iwasaki H, Ito K. Hurthle cell tumor of the thyroid: analysis of 188 cases. World J Surg 2001; 25:1160.
13. Kushchayeva Y, Duh QY, Kebemew E, Clark OH. Prognostic indications for Hürthle cell cancer. World J Surg 2004; 28:1266-1270.
14. Yutan E, Clark OH. Hurthle cell carcinoma. Curr Treat Options Oncol 2001; 2:331-335.
15. Chen H, Nicol TL, Zeiger MA, Dooley WC, Ladenson PW, Cooper DS, et al. Hurthle cell neoplasms of the thyroid: are there factors predictive of malignancy. Ovid Chen Ann Surg 1998; 227:542-546.
16. Carcangýu ML, Bianchi S, Savino D, Vaynick IM, Rasai J. Follicular Hurthle cell tumors of the thyroid. Cancer 1991; 68:1944-1953.
17. Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet 1974; 139:555-560.
18. Azadian A, Rosen IB, Walfish PG, Asa SL. Management considerations in Hurthle cell carcinoma. Surgery 1995; 118:711-715.